/Investor DB

Nextech Invest — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

PMV Pharmapmvpharma.comFeb 2017

PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations.

BiotechHealthtechLongevityCranbury, US

David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Co-Founder & Member, Scientific Advisory Board)David H. Mack(Co-Founder, President & CEO)Thomas Shenk(Co-Founder)Deepika Jalota(Chief Development Officer)

Co-investorsAvoro Capital AdvisorsOUP (Osage University Partners)RA CapitalViking GlobalWellington ManagementOrbiMed

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.